937808-67-8Relevant articles and documents
NO- AND H2S- RELEASING COMPOUNDS
-
Paragraph 0059; 0060, (2016/10/11)
This disclosure relates to novel compounds containing an H2S releasing moiety and a nitric oxide (NO) releasing moiety covalently linked with a core (e.g., a salicylic acid moiety) and the use of such compounds in treating inflammatory diseases, including
NOSH-aspirin: A novel nitric oxide-hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals
Kodela, Ravinder,Chattopadhyay, Mitali,Kashfi, Khosrow
scheme or table, p. 257 - 262 (2012/05/04)
A series of new hybrids of aspirin (ASA), bearing both nitric oxide (NO) and hydrogen sulfide (H2S)-releasing moieties were synthesized and designated as NOSH compounds (1-4). NOSH-1 (4-(3-thioxo-3H-1,2-dithiol-5-yl) phenyl 2-((4-(nitrooxy)buta
SALICYLIC ACID DERIVATIVES
-
Page/Page column 28, (2008/06/13)
The present invention refers to O-acyl salicylic acid derivatives (I) bearing a NO donor moiety, a process for their preparation and pharmaceutical compositions containing them. (I) wherein : D is ONO2 or (A).